Opioid peptides recently attracted much attention as low molecular weight compounds, which can target malignant cells expressing opioid receptors on their cell surface. Therefore opioid peptides have a potential to be introduced as radiopharmaceuticals. In this paper, we describe the method of conjugation of two bifunctional chelating agents (BFCAs), hydrazinopyridine-3-carboxylic acid (HYNIC) and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid (DOTA), to the N-terminal amino group of morphiceptin, endomorphin-2, and two of their analogs modified in position 3. GABA was used as a spacer molecule. mi-Opioid binding affinities of the peptides were compared with the binding affinities of BFCA-GABA-peptide conjugates. It was shown that the introduction of HYNIC to mi-opioid ligands causes only a slight decrease of -opioid receptor affinity, while DOTA-conjugates loose their affinity for mi-receptors completely.
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.